News

The review is part of a multi-pronged effort to curb opioid abuse nationwide.

Despite success in improving visual acuity, a study on CNTO-2476 was discontinued due to safety concerns.

The UNC-based research covered the period from January 2003 to December 2012, when most patients in the study were not covered by the most recent federal guidelines pertaining to HIV treatment.

COPD-related deaths increased 11.6% since 1990, and cases increased 44.2% to 174.5 million.

A new meta-analysis finds that better patient instruction can improve use and effectiveness of hand-held inhalers, and recommends closer scrutiny of how inhalers are mishandled.

How far can fecal microbial transplants take the cure for C. difficile and other diseases?

D-512 is an antioxidant combination drug that is the result of modified on-the-market receptor agonists.

Poverty and poor healthcare raise the trending global risks.

The study highlighted the need to intensify treatment for glycemic control sooner than current methods suggest.

Glucommander is now approved for various enhancements in its patient service capabilities.

A new estimate of the cost of corticosteroid-related morbidity has pulmonologists paying closer attention to steroid-sparing asthma treatments.

The seizure-causing condition now inflicts at least 3.4 million US patients, according to the CDC.

Three-dimensional images of a key glutamate receptor could be helpful in developing new types of multiple sclerosis therapies.

The role in this risk may be exacerbated by access of pets and other animals.

A deal between Biogen and a large Puerto Rican pharmacy benefits manager will tie multiple sclerosis drug payments to clinical outcomes.

The CEO of a robotics firm says an “exosuit” developed to aid patients recovering from stroke can also be used to help MS patients maintain their mobility.

A triple drug combination effectively cured patients with hepatitis C virus after they had failed to respond to a combination of two oral direct acting antivirals.

Sulforaphane has been found to lower glucose production and improve control in T2D patients.

A new study suggests type 2 diabetes progresses, or perhaps begins, in a manner similar to prion diseases like mad cow disease.

The drug will receive a ruling on Aug. 25. It's currently approved to treat type 2 diabetes and obesity.

2 separate study examinations revealed that collaboration between PCPs and behavioral specialists can drastically improve adolescent mental health.

A recent study suggests that weight change should be considered in GDM screening for pregnant mothers.

Neurotoxin EB-001's fast treatment start-up and shorter duration could make for a different focal pain reliever.

Sofosbuvir-based direct acting antiviral combinations for hepatitis C virus were found as effective and well tolerated in elderly patients as in younger populations.

67% to 92% of surgical patients prescribed opioids reported having unused medication.

Accounting for patients’ calcium intake could one day decrease risk for C. difficile infection, according to a recent study.

The potential Hepatitis B adult vaccine has had a half-decade of rebuff to its drug application.

A single measurement of viral load is not enough to determine durable viral suppression in HIV patients.

“This study tells us that the opioid epidemic has made people sicker and killed more people, in spite of all the care we can provide in the ICU, including mechanical ventilation, acute dialysis, life support and round-the-clock care."